Results 21 to 30 of about 205,452 (211)
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. [PDF]
BackgroundThe value of induction chemotherapy (ICT) remains under investigation despite decades of research. New advancements in the field, specifically regarding the induction regimen of choice, have reignited interest in this approach for patients with
Cohen, EEW +6 more
core +1 more source
Head and neck squamous cell carcinoma survivorship care
Head and neck cancer is the seventh most commonly diagnosed cancer in Australia. More than 90% of these cancers are squamous cell carcinomas (SCCs). With advances in cancer therapies, survivorship care is becoming increasingly topical. In particular, general practitioners (GPs) will play an increasingly central part in the management of this unique ...
Joo, Koh +3 more
openaire +3 more sources
Hypoxia in Head and Neck Squamous Cell Carcinoma [PDF]
Hypoxia is a common feature in most of the solid tumors including head and neck squamous cell carcinoma (HNSCC). Hypoxia reflects the imbalance between oxygen consumption by the rapidly proliferating cancer cells and the insufficient oxygen delivery due to poor vascularization and blood supply.
John Zenghong Li +4 more
openaire +2 more sources
The aim of this study was to determine the methylation status of the genes encoding the vascular endothelial growth factor receptors and to evaluate the usefulness of VEGFR methylation as a prognostic indicator in head and neck squamous cell carcinoma ...
Yuki Misawa +10 more
doaj +1 more source
Circulating tumor cells in head and neck cancer: A review
Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures ...
Kyle P. McMullen +4 more
doaj +1 more source
Cetuximab in squamous cell head and neck carcinomas
The epidermal growth factor receptor (EGFR) antagonist, cetuximab, has recently been shown to enhance the effects of radiotherapy, and reports to date indicate that this effect occurs without any change in the pattern and severity of toxicity usually associated with head and neck radiation and/or chemotherapy (CT) administration.
GEBBIA, Vittorio +5 more
openaire +3 more sources
Oral squamous cell carcinoma of tongue: Histological risk assessment. A pilot study [PDF]
Background: More than 90% of malignant tumors diagnosed in the oral cavity are Oral Squamous Cell Carcinomas (OSCC) whose preferred location is the tongue.
Cebrián Carretero, José Luis +4 more
core +3 more sources
Oropharyngeal head and neck squamous cell carcinoma is a common malignant tumor in the oral cavity. High-risk human papillomavirus 16 infection is a major cause of oropharyngeal head and neck squamous cell carcinoma development.
Jianfeng Dong +5 more
doaj +1 more source
Correlation between T and N Stages of Head and Neck Squamous Cell Carcinoma
Background and Objective: Squamous cell carcinoma of the head and neck region is a common pathological entity. Advanced primary lesion (T) and neck node metastasis (N) both are bad prognostic features for the carcinoma.
Krishna Koirala +2 more
doaj +1 more source
Extracellular vesicles (EVs) are mediators of the immune system response. Encapsulated in EVs, microRNAs can be transferred between cancer and immune cells.
Elisangela de Paula Silva +13 more
doaj +1 more source

